We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+11.42%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.24%
AUM
$11.6B
AUM Growth
+$243M
(+2.1%)
Cap. Flow
-$770M
Cap. Flow
% of AUM
-6.61%
Top 10 Holdings %
Top 10 Hldgs %
17.24%
Holding
303
New
50
Increased
66
Reduced
133
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$102M |
| 2 |
S&P Global
SPGI
|
+$82.9M |
| 3 |
Intercontinental Exchange
ICE
|
+$72.4M |
| 4 |
Nike
NKE
|
+$55.5M |
| 5 |
Avery Dennison
AVY
|
+$49.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$95.4M |
| 2 |
TJX Companies
TJX
|
+$94.8M |
| 3 |
Chubb
CB
|
+$87.2M |
| 4 |
Intel
INTC
|
+$80.1M |
| 5 |
Union Pacific
UNP
|
+$73.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.27% |
| 2 | Technology | 17.63% |
| 3 | Consumer Discretionary | 13.42% |
| 4 | Industrials | 12.91% |
| 5 | Communication Services | 12.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Adobe
ADBE
$98.5B
| $109M | 0.94% |
839,959
+254,861
| +44% | +$29.9M |
|
27
Danaher
DHR
$138B
| $103M | 0.89% |
1,360,273
+222,521
| +20% | +$16.6M |
|
|
SCHW
28
Charles Schwab
SCHW
$181B
| $103M | 0.88% |
2,523,667
+1,038,361
| +70% | +$42.9M |
|
29
United Parcel Service
UPS
$89.5B
| $101M | 0.87% |
941,891
+74,140
| +9% | +$8.1M |
|
30
Aptiv
APTV
$12.3B
| $100M | 0.86% |
1,244,543
+278,346
| +29% | +$20.9M |
|
31
Celanese
CE
$4.91B
| $98.7M | 0.85% |
1,098,611
-362,343
| -25% | -$31.6M |
|
|
32
Biogen
BIIB
$30.7B
| $98.2M | 0.84% |
+359,107
| New | +$102M |
|
33
Nektar Therapeutics
NKTR
$2.41B
| $94.6M | 0.81% |
268,703
-10,549
| -4% | -$2.37M |
|
34
Broadcom
AVGO
$1.85T
| $94.2M | 0.81% |
4,304,270
+405,890
| +10% | +$8.36M |
|
35
Cooper Companies
COO
$14.2B
| $92.3M | 0.79% |
1,847,692
-66,332
| -3% | -$3.15M |
|
36
CME Group
CME
$96.1B
| $91.5M | 0.79% |
770,348
-50,947
| -6% | -$6.13M |
|
|
TFCFA
37
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $89.1M | 0.76% |
2,750,026
+416,503
| +18% | +$12.7M |
|
38
PayPal
PYPL
$49.3B
| $87.2M | 0.75% |
2,027,866
-74,801
| -4% | -$3.13M |
|
|
39
S&P Global
SPGI
$122B
| $87.1M | 0.75% |
+666,502
| New | +$82.9M |
|
40
Icon
ICLR
$12.8B
| $75.2M | 0.65% |
942,754
+26,474
| +3% | +$2.17M |
|
41
Nexstar Media Group
NXST
$5.88B
| $74.8M | 0.64% |
1,066,853
-102,808
| -9% | -$6.89M |
|
|
42
Intercontinental Exchange
ICE
$87.7B
| $74.1M | 0.64% |
+1,237,295
| New | +$72.4M |
|
43
Applied Materials
AMAT
$398B
| $73.8M | 0.63% |
1,897,319
+5,647
| +0.3% | +$203K |
|
44
Pacira BioSciences
PCRX
$1.06B
| $73.4M | 0.63% |
1,608,847
+5,166
| +0.3% | +$223K |
|
45
Middleby
MIDD
$6.03B
| $73.3M | 0.63% |
537,165
-100,960
| -16% | -$13.7M |
|
46
GE Aerospace
GE
$368B
| $73.1M | 0.63% |
512,103
-37,773
| -7% | -$5.47M |
|
47
Mastercard
MA
$510B
| $72.4M | 0.62% |
643,716
-17,669
| -3% | -$1.94M |
|
48
TransDigm Group
TDG
$69.9B
| $71.6M | 0.62% |
325,439
+18,463
| +6% | +$4.41M |
|
49
Booking.com
BKNG
$150B
| $69.1M | 0.59% |
971,000
-25,425
| -3% | -$1.68M |
|
|
BERY
50
DELISTED
Berry Global Group, Inc.
BERY
| $68.9M | 0.59% |
1,544,393
-125,572
| -8% | -$5.78M |
|
Similar funds
OAG
JG
CHP
SAM
Westfield Capital Management's Q1 2017 Portfolio in Review
As of Q1 2017, Westfield Capital Management held 303 positions worth $11.6B, up 2.1% from $11.4B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Westfield Capital Management withdrew a net $770M in Q1 2017, closing 45 positions and reducing 133 holdings. Its most notable exit was TJX Companies, an estimated $94.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Westfield Capital Management opened a new position in Biogen worth $98.2M.
- Westfield Capital Management's largest Q1 2017 buy was Biogen: 359,107 shares worth $98.2M.
- Westfield Capital Management added most to Walt Disney in Q1 2017, an estimated $48.8M increase.
- Westfield Capital Management's biggest Q1 2017 reduction was Gilead Sciences, cutting an estimated $95.4M.
- Westfield Capital Management fully exited TJX Companies in Q1 2017, selling an estimated $94.8M.
- Westfield Capital Management's ten largest holdings make up 17% of its $11.6B portfolio in Q1 2017.
- Westfield Capital Management opened 50 new positions and closed 45 in Q1 2017.
- Westfield Capital Management's portfolio value rose 2.1% quarter-over-quarter to $11.6B.
Based on Westfield Capital Management's 13F filing for Q1 2017, filed 12 May 2017.